Axel S. Merseburger - Publications, H-index & Citations

Axel S. Merseburger

university of kiel

63H指数

849论文数

2.4W被引数

收录论文 197

发表时间

Corrigendum to “Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis” [Eur. Urol. Oncol. 8(5) (2025) 1340–1349]勘误：“Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis” [Eur. Urol. Oncol. 8(5) (2025) 1340–1349]

European Urology Oncology

IF9.3

2025-12-30

OAAI

Rossella Nicoletti; Alex Qinyang Liu; Susan Evans-Axelsson; Asieh Golozar; Katharina Beyer; Bertrand De Meulder; Riccardo Campi; Mauro Gacci; Jeremy Yuen-Chun Teoh; Carl Steinbesser; Ayman Hijazy; Artem Harbachou; James T. Brash; Peter-Paul M. Willemse; Teemu Murtola; Monique J. Roobol; Jesus Moreno Sierra; Anders Bjartell; Axel S. Merseburger; Pawel Rajwa

Stones and DNA damage - current perspectives in urology 结石与DNA损伤——泌尿外科学术界的最新观点

Aktuelle Urologie

IF0.4

2025-12-01

PREAI

Borkowetz, Angelika; Merseburger, Axel S.

Influence of MRI fusion biopsy on treatment recommendations How reliable are biopsy results?MRI融合活检对治疗建议的影响活检结果的可靠性如何？

UROLOGIE

IF0.4

2025-12-01

OAAI

Schildhauer, P.; Muller, M.; Merseburger, A. S.; Weiler, S. M.; Furschke, A.; Elser, Y.; Moderegger, A.; Fender, H. E.

Reply to Parth Aphale, Shashank Dokania, Himanshu Shekhar’s Letter to the Editor re: Bahl A, Chilelli A, Faria R, et al. Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study. World J Urol 43:465. https://doi.org/10.1007/s00345-025-05841-9 回复Parth Aphale、Shashank Dokania、Himanshu Shekhar致编辑的信函：关于Bahl A、Chilelli A、Faria R等人撰写的“乙酸盐比卡鲁他胺与恩杂鲁胺在转移性去势抵抗性前列腺癌患者中主要心血管事件关联性的比较：EVADE研究的事后分析”一文。World J Urol 43:465。https://doi.org/10.1007/s00345-025-05841-9

World Journal of Urology

IF2.9

2025-11-27

OAAI

Amit Bahl; Andrew Chilelli; Rita Faria; Nigel Rozario; Robert Snijder; Sari Stark; Axel S. Merseburger

Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis 比较性生存分析：激素敏感性转移性前列腺癌按疾病体积和转移时间划分——一项动态网络Meta分析

European Urology

IF25.2

2025-11-04

PREAI

Irbaz Bin Riaz; Syed Arsalan Ahmed Naqvi; Kunwer Sufyan Faisal; Huan He; Kaneez Zahra Rubab Khakwani; Daniel S. Childs; Jacob J. Orme; Praful Ravi; Parminder Singh; Syed A. Hussain; Kim Chi; Neeraj Agarwal; Axel S. Merseburger; Ian D. Davis; Andrew Armstrong; Maha H. Hussain; Matthew Smith; Gerhardt Attard; Bertrand Tombal; Karim Fizazi; Nick James; Aurelius Omlin; Silke Gillessen; Mohammad Hassan Murad; Eliezer M. Van Allen; Christopher J. Sweeney; Alan Haruo Bryce

New Prostate Cancer Guideline: Is Biopsy of PI-RADS 3 Lesions Meaningful? The Role of Multiparametric MRI-Ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer 新前列腺癌指南：PI-RADS 3级病灶的活检有意义吗？多参数MRI-超声融合活检在检测临床显著前列腺癌中的作用

Aktuelle Urologie

IF0.4

2025-11-01

PREAI

Schildhauer, Paul; Muller, Marten; Merseburger, Axel S.; Furschke, Alexander; Elser, Yannic; Moderegger, Anton; Fender, Hendrik Eike

Treatment Trajectories in Metastatic Hormone-sensitive Prostate Cancer: A PIONEER+ Big Data Analysis 激素敏感性转移性前列腺癌的治疗轨迹：一项PIONEER+大数据分析

European Urology Oncology

IF9.3

2025-10-08

OAAI

Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey 指导晚期尿路上皮癌一线治疗决策：一项全球调查

ONCOLOGIST

IF4.2

2025-10-01

OAAI

Grande, Enrique; Bellmunt, Joaquim; Hussain, Syed A.; Al Mansour, Mubarak M.; Bamias, Aristotle; Barthelemy, Philippe; Benjamin, David J.; Blais, Normand; Bourlon, Maria T.; Castellano, Daniel; Danchaivijitr, Pongwut; Fernandez Lazzaro, Mauricio; Giannatempo, Patrizia; Guerrero-Ramos, Felix; Iacovelli, Roberto; Ivanyi, Philipp; Jung, Eun Hee; Kanesvaran, Ravindran; Manneh, Ray; Marinho, Joana C.; Matsubara, Nobuaki; Merseburger, Axel S.; Mukherji, Deborah; Park, Chandler H.; Tran, Ben; da Trindade, Karine Martins; Urun, Yuksel; Kamat, Ashish M.; Birtle, Alison J.

CONTACT-02: limited clinical benefit and a suboptimal control group – Authors' reply CONTACT-02：有限的临床获益和不理想的对照组——作者回复

The Lancet Oncology

IF0

2025-09-29

PREAI

Neeraj Agarwal; Axel S Merseburger; Svetlana Andrianova; Arun A Azad

Apalutamide in Patients with High Burden of Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of TITAN 阿帕卢他胺在转移性激素敏感前列腺癌高负担患者中的疗效：TITAN研究的亚组分析

European Urology Oncology

IF9.3

2025-09-29

OAAI

Alejo Rodriguez-Vida; Angel Borque; Fernando Lopez-Campos; Alvaro Juarez Soto; Beatriz Garcillan; Cristian Vidal; Joana Lencart; Amitabha Bhaumik; Suneel D. Mundle; Suzy Van Sanden; Kim N. Chi; Anders Bjartell; Neeraj Agarwal; Axel S. Merseburger

Glans necrosis following penile procedures: a systematic review of etiology, frequency, and management 龟头坏死后行阴茎手术：病因学、发生频率及管理的系统综述

International Journal of Impotence Research

IF2.5

2025-08-18

PREAI

Berk Hazir; Axel Stuart Merseburger; Marie Christine Roesch; Daniar Osmonov

Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study 醋酸阿比特龙与恩扎卢amide在转移性去势抵抗性前列腺癌患者中主要心血管事件关联性的比较：EVADE研究的事后分析

World Journal of Urology

IF2.9

2025-08-01

OAAI

Amit Bahl; Andrew Chilelli; Rita Faria; Nigel Rozario; Robert Snijder; Sari Stark; Axel S. Merseburger

Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial 卡博替尼联合阿替利珠单抗在转移性前列腺癌中的研究（CONTACT-02）：一项III期、开放标签、随机试验的最终分析

lancet oncology

IF0

2025-06-13

PREAI

Neeraj Agarwal; Arun A Azad; Joan Carles; Nobuaki Matsubara; Stéphane Oudard; Fred Saad; Axel S Merseburger; Andrey Soares; Bradley A McGregor; Bogdan Zurawski; Marinos Tsiatas; Scott North; Igor Bondarenko; Margarita Alfie; Evangelos Bournakis; Lorenzo Antonuzzo; Lena Evilevitch; Andrew Simmons; Fong Wang; Roberta Ferraldeschi; Prachi Nandoskar; Sumanta K Pal

Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer 阿帕卢他胺治疗后极低的前列腺特异性抗原谷值：同步性对异时性转移性激素敏感性前列腺癌的结局

European Urology Open Science

IF4.5

2025-06-03

PREAI

Mike Wenzel; Thomas Steuber; Carolin Siech; Maximilian Kriegmair; Benedikt Hoeh; Derya Tilki; Axel S. Merseburger; Felix K.H. Chun; Philipp Mandel

DIAGNOSING PENILE FRACTURES: A RETROSPECTIVE COMPARISON OF MRI IMAGING AND ULTRASOUND 诊断阴茎骨折：MRI成像与超声的回顾性比较

JOURNAL OF SEXUAL MEDICINE

IF3.3

2025-05-09

PREAI

Morische, S.; Gilbert, N.; Merseburger, A. S.; Brozat-Essen, S.

Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life—A Systematic Review and Meta-analysis 雄激素受体通路抑制剂单药治疗在前列腺癌中的应用：安全性、肿瘤学结局及生活质量——一项系统评价和Meta分析

European Urology Focus

IF5.6

2025-05-01

OAAI

Tamás Fazekas; Marcin Miszczyk; Alexander Giesen; Tamás Kói; Fabio Zattoni; Lara Rodriguez-Sanchez; Takafumi Yanagisawa; Akihiro Matsukawa; Tibor Szarvas; Piotr Kryst; Juan Gómez Rivas; Axel S. Merseburger; Maria De Santis; Steven Joniau; Alberto Briganti; Giancarlo Marra; Péter Nyirády; Giorgio Gandaglia; Shahrokh F. Shariat; Pawel Rajwa

Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Systematic Review and Meta-analysis 前列腺特异性抗原应答作为接受雄激素受体通路抑制剂治疗的前列腺癌患者总生存期的预后因素：一项系统评价和荟萃分析

European Urology Focus

IF5.6

2025-05-01

OAAI

Marcin Miszczyk; Tamás Fazekas; Paweł Rajwa; Akihiro Matsukawa; Ichiro Tsuboi; Michael S. Leapman; Gero Kramer; Maha Hussain; Axel Merseburger; Alberto Briganti; Anthony V. D’Amico; Silke Gillessen; Fred Saad; Shahrokh F. Shariat

Cardiovascular Risks and Survival with Abiraterone vs Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer in Germany: AVENGER Study

ADVANCES IN THERAPY

IF4

2025-04-01

OAAI

Merseburger, Axel S.; Dornstauder, Eugen; Ohlmann, Carsten-Henning; Aprikian, Armen; Junker, Sophia; Hahn, Philipp; Chilelli, Andrew; Stoelzel, Matthias; Serikoff, Alexis; Spitzer, Stefan G.

Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial 进展性前列腺癌患者开始使用多西他赛联合或不联合恩扎卢替尼时的液体活检：PRESIDE 3b期试验的生物标志物研究

EUROPEAN UROLOGY ONCOLOGY

IF9.3

2025-02-01

OAAI

Ruiz-Vico, Maria; Wetterskog, Daniel; Orlando, Francesco; Thakali, Suparna; Wingate, Anna; Jayaram, Anuradha; Cremaschi, Paolo; Vainauskas, Osvaldas; Brighi, Nicole; Castellano-Gauna, Daniel; Astrom, Lennart; Matveev, Vsevolod B.; Bracarda, Sergio; Esen, Adil; Feyerabend, Susan; Senkus, Elzbieta; Piqueras, Marta Lopez-Brea; Gupta, Santosh; Wenstrup, Rick; Boysen, Gunther; Martins, Karla; Iwata, Kenneth; Chowdhury, Simon; Gourgioti, Georgia; Serikoff, Alexis; Gonzalez-Billalabeitia, Enrique; Merseburger, Axel S.; Demichelis, Francesca; Attard, Gerhardt

An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial 膀胱肿瘤整体切除术与传统经尿道膀胱肿瘤切除术的国际多中心随机对照试验: 膀胱尿路上皮癌整体切除术 (EBRUC) II试验的第一个结果

BJU INTERNATIONAL

IF4.4

2024-10-27

OAAI

Struck, Julian Peter; Moharam, Nadim; Leitenberger, Armin; Weber, Joerg; Lusuardi, Lukas; Oswald, David; Rassweiler, Jens J.; Fiedler, Marcel; Hornak, Jakub; Babjuk, Marek; Micali, Salvatore; Zaraca, Carlo; Spreu, Thomas; Friedersdorff, Frank; Borgmann, Hendrik; Merseburger, Axel S.; Kramer, Mario W.

研究方向